FindTrial
Sign In

Sepsis in India Prevalence Study

Prevalence of sepsis in critically ill patients in India: A single-day, prospective, observational, multicentre, nation-wide point-prevalence study - SIPS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/05/019125
Enrollment
1000
Registered
2019-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A418- Other specified sepsis

Interventions

Intervention1: NIL: NIL

Sponsors

The George Institute for Global Health
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients (18 years or older) present in the ICU at the start of the study day or admitted during the 24-hour study period will be included in the study sample.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The primary objective of this project is to examine sepsis epidemiology and characterize the antibiotic use and antimicrobial resistance in Indian ICUs.Timepoint: 24 hours—

Secondary

MeasureTime frame
To describe hospital level antibiotic stewardship practicesTimepoint: NA;To describe ICU level processes of careTimepoint: NA;To describe sepsis patient clinical characteristics, antimicrobial use, treatments received, and 30 day outcomes Timepoint: Day 30;To describe the antibiotic usage and antimicrobial resistance in Indian ICUsTimepoint: NA;To undertake a gender specific analysis to determine if prevalence, characteristics and outcomes of male and female patients with sepsis differTimepoint: NA—

Countries

India

Contacts

Public ContactBala Venkatesh

The George Institute for Global Health

bvenkatesh@georgeinstitute.org.au434980385

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026